|Articles|June 8, 2017
Exom Group starts Caravaggio Study, Cloud & Mobile Clinical Trial
Advertisement
Exom Group launched the Caravaggio Study, a Cloud & Mobile Clinical Trial, that will randomize around 1, 200 patients from 160 clinical sites spanning Europe, Israel, and the U.S.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
Streamlining Clinical Data to Reduce Site and Participant Burden
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
